An observational study in Pancreatic Cancer, sponsored by Seoul National University Hospital. Completed at 1 site in Korea, Republic of. Per ClinicalTrials.gov, last updated 2016-05-27.
Sponsored by Seoul National University Hospital · Observational
The purpose of this study is to determine whether there is a difference of diagnostic accuracy between cover slides and base slides from EUS-FNA cytopathologic sample in patients who were previously suspected of pancreatic cancer in radiologic test.
background
Samples from EUS-FNA are sent to following three types of preparations.
Method
In these manner, we collect the all subjects' cytopathologic results as a pair of outcome. All the possible combinations are following four examples:
3,235 studies on the registry are indexed under Pancreatic Neoplasms; 899 are open to participants now.
This study's enrollment of 73 is below the median of 200 across 620 observational studies indexed under Pancreatic Neoplasms.
Browse Pancreatic Neoplasms studies →Seoul National University Hospital is the lead sponsor of 1,860 studies on the registry; 275 are open to participants now.
Of its 12 completed or terminated interventional studies of FDA-regulated products, 2 (17%) have results posted.
Counted across the registry records on this site, refreshed daily.
The patients who visited to tertiary medical center(Seoul National University Bundang Hospital) because of suspicious pancreatic cancer in radiologic study
Exclusion Criteria:
positive malignancy rate of cover slides set and base slides set.
comparison between diagnostic accuracy between cover slide sets and base slide sets
Time frame: cytopathological report within 2 weeks after EUS-FNA
positive malignancy rate of (1) cytologic smear, (2) cell block and (3) histologic biopsy
comparison of three types of test in rate of positive malignancy
Time frame: record of pathologist within 2 weeks after EUS-FNA
This study is completed, as verified in Jul 2015. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Seoul National University Hospital